معرفی
James O'Connor is a Clinical Professor of Radiology at the University of Manchester's Division of Cancer Sciences and an Honorary Consultant Radiologist at The Christie Hospital. He holds a Cancer Research UK Advanced Clinician Scientist Fellowship focusing on MRI biomarkers for cancer drug-radiotherapy combinations. His research group, the Quantitative Biomedical Imaging Laboratory (QBI Lab), develops imaging biomarkers for solid tumors and hypoxia modification studies.
- Educated at Magdalene College (Cambridge) and Royal Free Hospital (London), with a PhD from Manchester (2009)
- Leadership roles include co-leading Cancer Research UK's National Cancer Imaging Translational Accelerator (NCITA)
- Key achievements: Developed imaging biomarker 'roadmap' adopted by CRUK, led national training programs for cancer imagers
Research interests span MRI biomarker validation, oncology imaging, and clinical applications of imaging techniques. Collaborates with institutions including UCL, Oxford, and Eli Lilly. Active in professional societies like ISMRM and ESMI.
Recent work includes studies on oxygen-enhanced MRI for radiation response (2024), imaging biomarkers for hypoxia modifiers (2024), and volunteer imaging for radiotherapy workflows (2025).
- Awards: CRUK Fellowships (2012/2016), ESTRO-Accuray Award (2018)
- Lab members: 7 PhD students/postdocs managing biomarker development projects
